These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 32405023)

  • 21. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
    Carradori S
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):85-87. PubMed ID: 32213152
    [No Abstract]   [Full Text] [Related]  

  • 22. Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement.
    Paladugu S; Donato AA
    Ann Intern Med; 2020 Jul; 173(2):JC4. PubMed ID: 32687756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [COVID-19: a cardiological point-of-view].
    Weckbach LT; Kellnar A; Stremmel C; Stark K; Kääb S
    Dtsch Med Wochenschr; 2020 Jul; 145(15):1063-1067. PubMed ID: 32731280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protect Pregnant and Lactating Women with COVID-19 Through Research, Not from Research.
    Stuebe A
    Breastfeed Med; 2020 Jun; 15(6):423-424. PubMed ID: 32420755
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chloroquine as a possible treatment for COVID-19].
    Coumou J; de Vries PJ
    Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32391999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remdesivir for COVID-19: challenges of underpowered studies.
    Norrie JD
    Lancet; 2020 May; 395(10236):1525-1527. PubMed ID: 32423580
    [No Abstract]   [Full Text] [Related]  

  • 28. The 11th Trial of a Cardiovascular Clinical Trialist-Coronavirus-2, Part 3.
    Frishman WH
    Cardiol Rev; 2020; 28(6):273-274. PubMed ID: 33017362
    [No Abstract]   [Full Text] [Related]  

  • 29. Understanding of COVID-19 based on current evidence.
    Sun P; Lu X; Xu C; Sun W; Pan B
    J Med Virol; 2020 Jun; 92(6):548-551. PubMed ID: 32096567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.
    Spinelli FR; Ceccarelli F; Di Franco M; Conti F
    Ann Rheum Dis; 2020 May; 79(5):666-667. PubMed ID: 32241791
    [No Abstract]   [Full Text] [Related]  

  • 31. COVID-19 Therapeutics: Making Sense of It All.
    Bakare LS; Allen JM
    AACN Adv Crit Care; 2020 Sep; 31(3):239-249. PubMed ID: 32668460
    [No Abstract]   [Full Text] [Related]  

  • 32. Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies.
    Marouf BH; Dizaye K
    Drug Discov Ther; 2020; 14(3):109-116. PubMed ID: 32669519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicines for the Treatment Of COVID-19: Awaiting the Evidence.
    Marto N; Monteiro EC
    Acta Med Port; 2020 Jul; 33(7-8):500-504. PubMed ID: 32425152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remdesivir as a possible therapeutic option for the COVID-19.
    Al-Tawfiq JA; Al-Homoud AH; Memish ZA
    Travel Med Infect Dis; 2020; 34():101615. PubMed ID: 32145386
    [No Abstract]   [Full Text] [Related]  

  • 35. Compassionate use of others' immunity - understanding gut microbiome in Covid-19.
    Thalanayar Muthukrishnan P; Faillace R
    Crit Care; 2020 Jun; 24(1):358. PubMed ID: 32552848
    [No Abstract]   [Full Text] [Related]  

  • 36. Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence.
    Khambholja K; Asudani D
    Travel Med Infect Dis; 2020; 35():101710. PubMed ID: 32360327
    [No Abstract]   [Full Text] [Related]  

  • 37. An update on novel COVID-19 pandemic: a battle between humans and virus.
    Prajapati S; Sharma M; Kumar A; Gupta P; Narasimha Kumar GV
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5819-5829. PubMed ID: 32495921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Finding Effective Treatments for COVID-19: Scientific Integrity and Public Confidence in a Time of Crisis.
    Goodman JL; Borio L
    JAMA; 2020 May; 323(19):1899-1900. PubMed ID: 32297900
    [No Abstract]   [Full Text] [Related]  

  • 39. Advances in SARS-CoV-2: a systematic review.
    Bai YX; Xu YH; Wang X; Sun C; Guo Y; Qiu S; Ma KW
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9208-9215. PubMed ID: 32965016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dozens of coronavirus drugs are in development - what happens next?
    Ledford H
    Nature; 2020 May; 581(7808):247-248. PubMed ID: 32409766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.